Harbor MedTech, Inc.

Harbor MedTech is a commercial-stage regenerative medicine company specializing in advanced orthopedic soft tissue repair solutions. The company's proprietary BriDGE® technology transforms Type-1 collagen into a bio-friendly, stabilized collagen matrix that activates the patient's natural healing cascade. Clinical and pre-clinical evidence demonstrates efficacy in accelerating wound healing, supporting tissue regeneration, reducing scar tissue formation, and limiting infectious biofilm development. The company currently markets two FDA-cleared and CE-marked products, with a pipeline addressing orthobiologic soft tissue injuries (sports medicine), general surgical repair (hernia and breast reconstruction), and chronic skin wound management.